Hypertrust Main logo

HPDC releases a New Version of The Hypertrust X-Chain with Intuitive UI

München (DE), Boston (US), March 8th, 2023 Hypertrust Patient Data Care (HPDC) today released a first beta version of its Hypertrust X-Chain Supply Chain Management solution for ATMP (Advanced Therapy Medicinal Products) to selected customers. Version 3.0 of the solution will be generally available in Q2 2023. The refreshed and extended version features a completely new user experience, as well as streamlined workflow designing capabilities. With Hypertrust X-Chain, biotech and pharmaceutical companies can design, set up, plan, orchestrate, operate, and scale ATMP supply chains with a single system – securely and in full compliance with relevant standards and GMP guidelines.
“We are pleased to have taken the Supply Chain Management of ATMP to the next level with the new release of Hypertrust X-Chain”, commented Andreas Göbel, Managing Director at Hypertrust Patient Data Care. “Our end-to-end supply chain solution enables intuitive inclusion of all stakeholders and multidirectional orchestration of all supply chain partners – making ATMP supply chains even smoother.” In addition, the solution allows easy modeling of cell and gene therapy processes, which is particularly important for new therapeutical approaches and manufacturing models.”

Comprehensive Benefits for All Users

HPDC has been continuously enhancing its cell & gene therapy orchestration (C&GTO) solution Hypertrust X-Chain in terms of GMP standards, user experience, and flexibility. As a result, the system can be easily configured and customized based on “no-code” principles as well as implemented and validated in a short period of time. With the latest version, users now benefit from:

  • Fast and easy process development through no-code protocol, data model and rules designer
  • Alpha Design System By using modular components, the Alpha Design System ensures the creation of consistent and efficient user interfaces.
  • Seamless Experience Hypertrust X-Chain provides a cohesive user experience for simple or complex scenarios by combining usability with enterprise-level collaboration.
  • Responsive Design allows users to use Hypertrust X-Chain on any device, even on tablets used on shop or hospital floors.
  • A fully integrated cross-company scheduler helps to build a powerful operational planning engine.
  • Data regulation compliance module for GDPR compliance in commercial environments.

This allows every company to deploy Hypertrust X-Chain cell & gene therapy orchestration solution exactly according to its needs and use it in every relevant scenario at the touch of a button. As in the previous versions, patient centricity is still at the core of the solution, ensuring that involved physicians do not have to worry about supply chain challenges. In addition, the use of Hypertrust X-Chain is flexible – and can seamlessly be operated in centralized, decentralized, and hybrid manufacturing models.

Live Demos at Supply Chain & Logistics for Cell Therapies Summit 2023 in Boston

The new Hypertrust X-Chain solution will be presented at the Supply Chain & Logistics for Cell Therapies Summit 2023, the world’s leading supply chain summit for the cell therapy community, March 7-9 in Boston, USA. The HPDC team will be available to provide detailed information and live demos to conference visitors. In addition, Managing Director Andreas Göbel, together with Supply Chain experts Karim Bitar and Thomas Ebel from CAMELOT Management Consultants, will provide insights into “Proven Models, Strategies and Methodologies to Make Your CGT Supply Chain a Commercial Success” on March 9 at noon.


Get to know the world-wide first supply chain planning solution to infuse resilience, intelligence, and excellence into your operations with zero latency on all levels.
Hypertrust Main logo

Book a Demo